Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Rifampicin and Efavirenz Interaction in HIV-TB Co-infection
NCT01986543Phase 2Unknown
- Sponsor
- ANRS
- Start
- Dec 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin, efavirenz in Tuberculosis (TB), human immunodeficiency virus infection (HIV), sponsored by ANRS. Status: unknown.
02
Drugs
rifampicinefavirenz
03
Conditions
Tuberculosis (TB)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01986543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986543.